CS Paper Radar

Agentic LLM reasoning in pediatric diabetes outcome prediction from multimodal medical records

Daniel Palacios, Guantong Qi, Anna Kadi, Natali Borrego, Sukru Aras, Michael L. Ferm, Elizabeth Kubota-Mishra, Maria J. Redondo, Zhandong Liu, Mustafa Tosur, Hu Chen

cs.CL q-bio.QM ·submitted 2026-10-29 16:23 UTC · v1

Abstract

Large language model (LLM) agents are proposed for clinical prediction but are untested in pediatrics, where cohorts are small and outcomes are uncommon. Using records from 2,489 youth with type 2 diabetes (T2D) and 4,018 with type 1 diabetes (T1D), spanning structured data, note-derived social determinants and, in T1D, continuous glucose monitoring data, we predicted seven T2D outcomes, four also in T1D, at 24 months from 18 months of follow-up. CEDAR (Clinical Evidence-Driven Agent for Risk-prediction), an evidence-citing, self-auditing LLM pipeline, outperformed trained machine learning in both cohorts (pooled area under the receiver operating characteristic curve 0.815 versus 0.656 to 0.700 in T2D and 0.756 versus 0.603 to 0.631 in T1D), most on the sparsely screened outcomes. Only 4 of 70,246 values it cited did not match the chart. Reading only the evidence and reasoning cited by CEDAR, two pediatric endocrinologists reached the same prediction as CEDAR in about nine of ten cases, agreeing with each other on 90.5%.

Comment
18 pages main text plus 40 pages Supplementary Information

Closest papers

Nearest neighbours by meaning across the whole index.

It's All in the Way You Say It: The Role of Information Representation in LLM-Based Glycemic-Event Prediction

cs.AI ·2026-09-08 ·Andrea Apicella, Pasquale Arpaia, Matteo Orefice, Andrea Pollastro, Roberto Prevete
similarity 0.66
Abstract · Submitted to a journal for peer-review

Large Language Models (LLMs) are increasingly being investigated for physiological time-series prediction, yet their effectiveness may depend not only on the model itself, but also on how physiological information is represented and presented at inference time. This study investigates prompt-based general-purpose LLMs for postprandial hyperglycemia and hypoglycemia prediction in individuals with type 1 diabetes. Using the OhioT1DM dataset, we evaluate multiple open-weight LLMs under zero-shot and few-shot inference across prediction horizons of 30, 60, and 90 minutes. The analysis varies both the textual representation of the available physiological information and the amount of information exposed to the model, ranging from glucose observations alone to derived descriptors and additional contextual variables related to insulin, meals, carbohydrates, and physical activity. Performance is compared with conventional patient-specific supervised models and with Gluco-LLM, a language-model-based architecture explicitly adapted to glucose time-series forecasting. Results show a marked task-dependent behavior. Conventional supervised models achieve the strongest performance for hyperglycemia prediction, whereas the best observed prompt-based LLM configurations improve performance for hypoglycemia across all investigated horizons. The effectiveness of prompt-based inference is also strongly influenced by how physiological information is represented, while providing additional contextual information does not lead to a systematic improvement. Overall, these findings highlight physiological information representation as a central design factor in prompt-based LLM approaches to glycemic-event prediction.

0.35

SSMCGM-Stream: A Streaming State-Space Model for Personalized Diabetes Management

cs.LG cs.AI ·2026-10-20 ·Shakson Isaac, Chirag Patel
top venue similarity 0.66
Abstract · Accepted to AI4Science and GenAI4Health NeurIPS 2026 workshops

Continuous glucose monitoring supports diabetes management but requires forecasting models that are accurate, interpretable, and efficient enough for real-time deployment. We present SSMCGM-Stream, a streaming state-space model that maintains a personalized hidden state updated with each incoming glucose reading to provide constant-time forecasting, physiologically structured counterfactual reasoning, and interpretable forecasts through hidden-state attribution. Built on this foundation, SSMCGM-Agent delivers risk-aware, natural-language decision support by translating forecasts, explanations, and counterfactuals into grounded recommendations through a guarded language-model interface. Evaluated on the T1DEXI cohort, SSMCGM-Stream achieves forecasting performance comparable to strong neural baselines while substantially reducing computational cost, enabling continuous on-device diabetes decision support.

0.35

DIASENTINEL: An Auditable Multi-Agent System for Guideline-Grounded Diabetes Risk Screening

cs.CL ·2026-08-31 ·Yung Wei Shueh, Zhi-Jie Chen, Chia-Hsuan Hsu, Hsin-Ling Hsu, Donghua Zhang +7 more
top venue similarity 0.65
Abstract

Large language models (LLMs) offer promising clinical decision support but remain vulnerable to hallucinated facts, unsupported recommendations, and citation errors. We present DIASENTINEL, a fully on-premise multi-agent system for one-year type 2 diabetes mellitus (T2DM) risk screening and guideline-grounded report generation from electronic health records (EHRs). The system integrates calibrated risk prediction, deterministic clinical signal extraction, Reciprocal Rank Fusion over American Diabetes Association (ADA) guidelines, and a hybrid verification layer combining rule-based checks with LLM entailment. The demonstration provides a real-time batch-screening dashboard and an interactive patient report interface with cited recommendations, verification results, and raw EHR comparison. DIASENTINEL demonstrates a practical framework for reliable, auditable, and privacy-preserving LLM-based clinical decision support.

0.33

FairGlucose: A CGM Fairness Benchmark Reveals Subgroup Disparities Hidden in Population-Level Validation

cs.CY cs.AI ·2026-08-18 ·Junjie Luo, Xuzhe Zhi, Rui Han, Abhimanyu Kumbara, Anand K. Iyer +3 more
benchmark similarity 0.62
Abstract

As CGM-based AI tools approach clinical deployment, whether their accuracy is equitable across patient demographics remains insufficiently tested. To enable this evaluation, we constructed FairGlucose, a 300-patient CGM cohort balanced across 12 demographic strata (age x gender x type 1/type 2 diabetes), with 132,480 forecasting samples and 3,945 unique behavioral events (meals, exercise, medication) logged by 81 patients. Benchmarking 33 models across four families on 2-hour glucose forecasting, we find that population-level external validation can conceal substantial subgroup disparities. Aggregate out-of-distribution metrics appear stable (approximately 1.0), yet subgroup-level ratios range from 0.8 to 1.4, with T1D patients showing 6 mg/dL higher prediction error than T2D (p < 0.001). This disparity persists across all 33 models, suggesting a property of the prediction task rather than any single architecture. Further analysis shows that subgroup performance gaps align with the proportion of clinically hard cases, and that input-length sensitivity varies across demographics, motivating personalized configurations. Frontier LLMs underperform specialized neural models by 1-6 mg/dL; behavioral events contribute negligibly (approximately 0.1 mg/dL) even under oracle event access. These findings establish that population-level validation alone is insufficient for equity assessment of digital health AI, motivating subgroup-disaggregated reporting as a default standard.

0.29

Auditing evaluation artifacts and data leakage in large language model systems for rare disease diagnosis

cs.AI ·2026-10-24 ·Jian Yang, Peilin Liu, Xiaohan Li, Songda Li, Yu Cao +2 more
benchmark similarity 0.60
Abstract · 18 page, 3 figures

Augmented large language model (LLM) systems have reported high benchmark accuracies in rare disease diagnosis, yet their real-world clinical utility remains unproven. A recent meta-analysis flagged augmented LLM diagnostic evaluations as having a high risk of bias due to suspected data leakage; however, the precise impact of these vulnerabilities on model inference has yet to be fully quantified. In this study, we present a comprehensive empirical audit to quantify evaluation artifacts across prevailing AI paradigms, using a repository of over 60,000 cases from diverse public and independent clinical cohorts. By reconstructing a state-of-the-art agentic framework, we demonstrate that candidate-space contamination artificially inflates performance: enforcing strict cross-dataset isolation resulted in a marked performance decline, with the cross-dataset mean Recall@1 decreasing from 54.3% (under conventional one-vs-rest evaluation) to 40.3% (Hedges' g = 0.94). Similar spatial overfitting in supervised classifiers caused diagnostic accuracy to drop from an internal mean of 42.9% to 16.7% across external cohorts (Cohen's d = 2.01). Furthermore, we quantify how LLMs infer diagnoses by exploiting retrospective therapeutic cues in clinical narratives, and how temporal misalignment in foundational knowledge bases leads to performance fluctuations. We conclude that prevailing evaluation protocols for augmented LLM systems inadvertently reflect data leakage rather than genuine medical reasoning. To address these systematic artifacts, we propose a rigorous evaluation framework - coupling strict data-isolation protocols with standardized benchmarking safeguards - to ensure future diagnostic AI for rare diseases is evaluated on actual clinical robustness.

0.50

A primer on evaluation methods for large language models in healthcare

cs.CL cs.AI ·2026-09-13 ·Suzannah E McKinney, Phuc Vu, Samuel A Justice, Christopher Humphries, Alyssa Pradhan +8 more
similarity 0.60
Abstract

Large language models (LLMs) have a growing range of applications in medicine, and their evaluation is critical for ensuring they provide benefit and not harm. This evaluation can be more challenging than traditional machine learning for many reasons, including probabilistic and open-ended outputs, and behavior that shifts with prompt design and accumulated context. This review covers four key areas of LLM evaluation: principles of study design, statistical methods, capability evaluation and clinical application evaluation. Capability evaluation considers different benchmarks, including multiple-choice, agentic and multi-turn benchmarks, alongside operational metrics like token usage and latency. Clinical application evaluation addresses establishing accuracy of free text outputs, such as human review and LLM-as-a-judge, and clinical trial approaches. Across sections, we describe underlying concepts and potential pitfalls, while emphasizing the importance of aligning evaluation methods with the research question. Together, this article aims to provide a pragmatic basis for designing and executing rigorous evaluations of healthcare LLMs.

0.15

Beyond Binary Classification: Multiclass Machine Learning for Diabetes and Prediabetes Risk Prediction Using NHANES

cs.LG ·2026-11-12 ·Aman Mujahid, Anita Penkova
similarity 0.60
Abstract

Detecting diabetes risk early is important for preventing disease progression. Most existing machine learning approaches focus on binary classification, which limits their ability to capture intermediate risk states such as prediabetes. We develop a supervised learning framework to classify adults as normal, prediabetic, or diabetic using National Health and Nutrition Examination Survey data. The framework uses routinely collected demographic, clinical, and lifestyle variables from 15,356 adults, with glycated hemoglobin (HbA1c) used only to define labels and excluded from input features to prevent leakage. We compare conventional machine learning and transformer-based models and examine two binary formulations: normal versus prediabetes, and normal versus combined prediabetes and diabetes. Models are evaluated on a held-out test set using precision, sensitivity, specificity, and F1 score. In the multiclass setting, performance is broadly consistent across models, with accuracy up to 0.72 and macro-averaged F1 of 0.70. Prediabetes remains the most challenging class, with F1 scores of 0.54 to 0.56 for conventional models and 0.53 to 0.55 for transformers, reflecting its overlap with both neighboring states. When the task is reduced to normal versus prediabetes, F1 scores rise modestly to 0.62 to 0.64. A more substantial improvement is observed under a broader screening formulation combining prediabetes and diabetes, with F1 scores of 0.73 to 0.74 across all models. These findings suggest that feature overlap along the biological continuum between normal and diabetic states contributes more to the difficulty of prediabetes detection than model architecture. Multiclass prediction provides a more clinically informative representation of metabolic risk progression but highlights a trade-off between clinically meaningful stratification and predictive accuracy.

0.18

LongAgent: History-Guided Agentic Search for Longitudinal Outcome Prediction

cs.AI ·2026-09-14 ·Siyao Wang, Florian Guitton, Shuojie Fu, Guanyu Tao, Kai Sun +1 more
published similarity 0.59
Abstract · This paper is accepted to the MICCAI 2026 Agentic AI for Medicine Workshop

Extracting informative representations from longitudinal data that can predict future outcomes remains a critical challenge in medicine. Medical datasets are inherently heterogeneous, consisting of a large number of variables collected from different sources, sampled with different temporal spacings, and representing different aspects of human health status. This requires identifying those variables with predictive value, processing longitudinal information, and integrating multiple variables for outcome prediction. Here, we propose a novel agent-based approach, LongAgent, that can autonomously search over combinations of variable sets, temporal windows and longitudinal aggregation functions, and identify candidates with promising predictive performance. LongAgent utilises a history memory of previous searches and numerical evidence to guide subsequent exploration. On synthetic data, LongAgent achieves a mean prediction RMSE of 1.7376 and improves over the strongest non-agent baseline by 0.0151 (95% CI: [0.0045,0.0260]; p=0.0273). On a real clinical dataset, it performs comparably to the best baseline.

0.19